跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ATORVASTATINA PENSA PHARMA 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ATORVASTATINA PENSA PHARMA 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
ATORVASTATINA PENSA PHARMA 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Towa Pharmaceutical S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Aug 28, 2023
Approval ID
b28f694e5c5fc230
Company
Towa Pharmaceutical S.A.
Type
Standard
Approval Details
Approval Id
b28f694e5c5fc230
Drug Cima Aemps Name
ATORVASTATINA PENSA PHARMA 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
89027
Holder Company Name
Towa Pharmaceutical S.A.
Marketing Company Name
Towa Pharmaceutical S.A.
Authorization Date
2023-08-28
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
40 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Towa Pharmaceutical S.A.
Active Ingredients
ATORVASTATINA CALCICA TRIHIDRATO
43,32 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Aug 28, 2023
Approval ID
b28f694e5c5fc230
Type
Standard
Back to CIMA-AEMPS Approvals